Details for New Drug Application (NDA): 211908
✉ Email this page to a colleague
The generic ingredient in ZIPRASIDONE MESYLATE is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
Summary for 211908
Tradename: | ZIPRASIDONE MESYLATE |
Applicant: | Gland Pharma Ltd |
Ingredient: | ziprasidone mesylate |
Patents: | 0 |
Suppliers and Packaging for NDA: 211908
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 211908 | ANDA | Dr.Reddy's Laboratories, Inc. | 43598-061 | 43598-061-58 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-061-58) / 1 mL in 1 VIAL, SINGLE-DOSE (43598-061-11) |
ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 211908 | ANDA | Dr.Reddy's Laboratories, Inc. | 43598-848 | 43598-848-58 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-848-58) / 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAMUSCULAR | Strength | EQ 20MG BASE/VIAL | ||||
Approval Date: | Dec 26, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription